Please login to the form below

Not currently logged in
Email:
Password:

Alkindi

This page shows the latest Alkindi news and features for those working in and with pharma, biotech and healthcare.

Diurnal files adrenal insufficiency drug Alkindi in US

Diurnal files adrenal insufficiency drug Alkindi in US

Could become only treatment for children with the condition. UK specialty drugmaker Diurnal has filed its Alkindi Sprinkle replacement therapy for children with adrenal insufficiency in the US, a group with ... The two halves of the Alkindi capsules are

Latest news

  • Resurgent Diurnal raises £5.4m for twin product filings Resurgent Diurnal raises £5.4m for twin product filings

    Both should be submitted before the end of the year. The funds will also be used to boost Diurnal’s European sales capacity as it continues to roll out Alkindi in ... Europe after its approval by the EMA last year, and to pursue licensing deals for

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Madmicrobe Studios - Medical Animation

MadMicrobe is an award-winning team of certified medical illustrators creating animations that engage your audience with immersive experiences that bring...

Latest intelligence

The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
Report: Omnichannel advice for the life science industry
In the latest issue of Delta magazine, Fishawack Health's Medical, Marketing, and Consulting experts share their practical advice for creating meaningful omnichannel stakeholder experiences and reveal our proprietary tool for...